Grauer & Weil India Limited DCF Valuation

GRAUWEIL · Chemicals · Current price ₹78.2

Full stock page
DocStoX fair value
₹74
medium confidence · 55/100
Current price
₹76
Upside to fair value
-2.1%
Estimate range
₹67 – ₹82
5Y profit growth
+18.9%
Model it yourself — DCF Calculator
Opens pre-filled with Grauer & Weil India Limited's latest numbers.

Grauer & Weil India Limited cash-flow valuation

Our engine did not use a discounted-cash-flow model for Grauer & Weil India Limited. It routes each business to the methods that suit it, and a DCF is a poor lens where cash-flow forecasts are fragile or the business is capital-structure driven. The methods it did use, and why, are set out below. Our published estimate is ₹74.

Try your own assumptions

Prefer to build the discounted cash flow yourself? The DCF calculator below opens pre-filled with Grauer & Weil India Limited's reported free cash flow, net debt and share count, so you can set your own growth and discount rate.

How we got this fair value

Every number below is part of the same estimate for Grauer & Weil India Limited. Nothing here is a target price or a forecast of where the share price will go.

Medium confidence55/100

Workable, with real gaps. Weigh it alongside your own view rather than on its own.

Estimate range ₹67 – ₹82

Why this method for this business

As a cyclical commodity chemical business, normalized mid-cycle earnings and EV/EBITDA are the most appropriate models. The EV/EBITDA model is particularly relevant given the capital intensity and the need to account for debt.

The models behind the number

Each method is weighted by how well its inputs held up for this company.

Normalized earnings (mid-cycle EV/EBITDA)
₹7470% weight

Cyclical valued off mid-cycle earnings and a through-cycle EV/EBITDA (§6.6)

EV / EBITDA(not enough data)

required inputs missing

  • DCF is not suitable for a cyclical commodity chemical business with volatile cash flows
  • Book value is not relevant for a capital-intensive business with significant debt

What was missing

  • Forward estimates are not available
  • No recent news impacting the business

What drives it

8 inputs, grouped by how strong each claim is
ReportedRead from filings or market data. Verifiable, not our opinion.
Revenue (TTM)
1,190 ₹ cr

computed

Net debt
15 ₹ cr

computed

Shares outstanding
45,25,74,526

computed

AssumptionA forward input the model chose. Reasonable people can disagree here.
EBITDA margin (cycle median)
16%

computed (≤5y median)

Through-cycle EV/EBITDA
17.78×

own-history (median of 5y)

DerivedFalls out of the inputs above: a model output, not an independent input.
Mid-cycle EBITDA
190.4 ₹ cr

computed

Enterprise value
3,385.2 ₹ cr

computed

Net debt basis
gross (cash unavailable)

note: net debt approximated by gross debt (cash unavailable)

Who computed this

A language model (qwen3:8b) selects the valuation method and the judgement inputs for Grauer & Weil India Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.

Estimated 15 Sept 2026. Re-run as new financials and news arrive.

How we value stocks

We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.

Read the full fair-value methodology

More on Grauer & Weil India Limited

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.